New cream could help men regrow hair, early study shows

NCT ID NCT05802173

Completed Disease control Sponsor: Technoderma Medicines Inc. Source: ClinicalTrials.gov ↗

First seen Nov 12, 2025 · Last updated Apr 30, 2026 · Updated 25 times

Summary

This study tested a new medication called TDM-105795 for male pattern baldness. 71 men with mild to moderate hair loss used the treatment or a placebo for 16 weeks. The goal was to see if the treatment increased hair count and improved hair growth compared to no treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Site 1

Austin, Texas, 78759, United States
Site 10

Minneapolis, Minnesota, 55455, United States
Site 11

Baton Rouge, Louisiana, 70809, United States
Site 12

North Little Rock, Arkansas, 72116, United States
Site 13

New Orleans, Louisiana, 70115, United States
Site 2

Norfolk, Virginia, 23502, United States
Site 3

Portland, Oregon, 97210, United States
Site 4

Rolling Meadows, Illinois, 60008, United States
Site 5

Knoxville, Tennessee, 37909, United States
Site 6

College Station, Texas, 77845, United States
Site 7

Plainfield, Indiana, 46168, United States
Site 8

Murfreesboro, Tennessee, 37130, United States
Site 9

New Brighton, Minnesota, 55112, United States

Conditions

Explore the condition pages connected to this study.

ALOPECIA, ANDROGENETIC